for regional diagnostic data platform

Conclusion wins tender from Glia Diagnostiek IT B.V.

Amsterdam healthcare organisations consolidate diagnostic data in a single open platform; Conclusion to deliver implementation and managed services

Conclusion has been awarded the tender by Glia Diagnostiek IT B.V., a collaboration between Amsterdam UMC, OLVG Lab and GGD Amsterdam. Conclusion will deliver and manage a regional digital platform that consolidates diagnostic data from multiple Amsterdam-based laboratories and makes it available to healthcare professionals, patients and researchers.

Diagnostic processes across the Amsterdam region are currently highly fragmented. Patients receive care from multiple providers, yet their laboratory results are not automatically shared. This leads to unnecessary duplication, such as repeat blood tests, and limits healthcare professionals’ insight into a patient’s full diagnostic history. At the same time, demand for complex diagnostics is increasing, while the availability of healthcare staff is under pressure. Glia Diagnostiek IT B.V. initiated the tender to address these structural challenges.

The solution delivered by Conclusion is deliberately designed as an open and modular platform: individual components can be replaced, and data can be transferred to other systems. This is enabled, among other things, through the use of openEHR, which structures healthcare data according to an international open standard. In addition, all platform components are cloud-agnostic, allowing the solution to be deployed in any cloud environment. This reduces vendor lock-in.

The platform brings together laboratory results from different healthcare organisations in one place, ensuring healthcare professionals always have a complete view. In a later phase, patients will also gain access to their own diagnostic data. For the delivery of the data foundation and associated lab-specific processes, Conclusion is partnering with CODE24, a specialist with extensive experience in openEHR database solutions and laboratory ordering and reporting processes.

Mark Elstgeest, director of business consultancy at Conclusion Benelux: “Regional collaboration on this scale in diagnostics is unique in the Netherlands and can serve as a model for the wider sector. There is a great deal of discussion around innovation in the healthcare chain, but ultimately it is about moving into execution. It is encouraging to see Glia Diagnostiek taking that step, based on an open standard and a modular architecture. This demonstrates how to organise sustainable innovation without becoming dependent on a single system or supplier. For Conclusion, this is exactly the type of partnership we value, where technology and healthcare expertise reinforce each other.”

Following an extensive selection process, Glia Diagnostiek IT B.V. awarded the contract to Conclusion. The proposed solution was assessed as the strongest from a technological perspective and aligned most closely with the client’s requirements and ambitions.

The first phase focuses on enabling the exchange of diagnostic information between healthcare professionals. This will be followed by scaling, with the ultimate goal of establishing a business-critical facility within the regional healthcare ecosystem. Thanks to its open standard and modular architecture, the platform can also be transferred to other regions or collaborative healthcare networks in the Netherlands.

Remmert Vosbergen, board member of Glia Diagnostiek IT B.V.: “With Conclusion, we are entering into a partnership with an organisation that has demonstrated it possesses the expertise and technology required to deliver an ambitious, future-proof digital platform within a complex healthcare environment. We have great confidence in the people we have met and in their vision for the future. We expect Conclusion to be more than just a supplier: a partner that works alongside us to build the digital foundation for the diagnostics of tomorrow. We look forward to this collaboration and to what we can achieve together.”